Chemical, Bioactivity, and Biosynthetic Screening of Epiphytic Fungus

Gisela A González-Montiel, Elizabeth N Kaweesa, Nicolas Feau, Richard C Hamelin, Jeffrey K Stone, Sandra Loesgen

Open access · goldAbstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

0.3field-weighted citation impact, top 40% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

Engineered Anti-Microbial Peptides Inhibit Cell Viability, Promote Apoptosis, and Induce Cell Cycle Arrest in SW620 Human Colon Adenocarcinoma Cells.Current protein & peptide science · 2025
Article
In Vitro Efficacy of Extracts and Isolated Bioactive Compounds from Ascomycota Fungi in the Treatment of Colorectal Cancer: A Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2022
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Gisela A González-MontielDepartment of Chemistry, Oregon State University, Corvallis, OR 97331, USA.

Elizabeth N KaweesaDepartment of Chemistry, Oregon State University, Corvallis, OR 97331, USA.

Nicolas FeauDepartment of Forest and Conservation Sciences, University of British Columbia, Vancouver, BC V6T 1ZA, Canada.ORCID 0000-0001-5925-9867

Richard C HamelinDepartment of Forest and Conservation Sciences, University of British Columbia, Vancouver, BC V6T 1ZA, Canada.

Jeffrey K StoneDepartment of Botany and Plant Pathology, Oregon State University, Corvallis, OR 97331, USA.ORCID 0000-0002-2898-6399

Sandra LoesgenDepartment of Chemistry, Oregon State University, Corvallis, OR 97331, USA.

Oregon State University · USUniversity of British Columbia · CA

Funding

National Science Foundation CHE 1808717

6 · The paper itself

Abstract

We report the first secondary metabolite, 8,8'-bijuglone, obtained from pure cultures of the slow growing Douglas fir- (

Indexed as

Biosynthetic PathwaysAnti-Bacterial AgentsAscomycotaCell ProliferationColonic NeoplasmsGenome, FungalGram-Positive BacteriaHCT116 CellsHumansNaphthoquinonesSecondary MetabolismAnti-Bacterial AgentsjugloneNaphthoquinones8,8′-bijuglonecytotoxic activityepiphytic fungigenome miningMycosphaerellaceaequinoneZasmidium pseudotsugae

Identifiers

PMID32438585

DOI10.3390/molecules25102358

PMCPMC7287617

OpenAlexW3027518449

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.